# LIAS

## Overview
The LIAS gene encodes the enzyme lipoic acid synthetase, which plays a pivotal role in mitochondrial metabolism by facilitating the biosynthesis of lipoic acid, a crucial cofactor for several enzyme complexes. Lipoic acid synthetase is categorized as an enzyme involved in the post-translational modification of proteins, specifically through the insertion of sulfur atoms into octanoyl groups to form lipoyl groups. These lipoyl groups are essential for the activity of key mitochondrial enzymes, such as pyruvate dehydrogenase and α-ketoglutarate dehydrogenase, which are integral to the citric acid cycle and energy production (Cronan2020Progress). The proper function of the LIAS gene is critical for maintaining normal metabolic processes, and mutations in this gene can lead to severe metabolic disorders, including glycine encephalopathy (Tsurusaki2015Novel). Additionally, LIAS interacts with other proteins, such as FDX1, to regulate cellular protein lipoylation, further underscoring its importance in cellular metabolism and energy homeostasis (Dreishpoon2023FDX1).

## Structure
The LIAS (lipoic acid synthetase) protein is integral to the biosynthesis of lipoic acid, a vital cofactor for mitochondrial enzyme complexes. Its primary structure is composed of a sequence of amino acids encoded by the LIAS gene. The secondary structure of LIAS includes alpha helices and beta sheets, which contribute to its stability and function. The tertiary structure of LIAS forms a three-dimensional shape that is crucial for its enzymatic activity, allowing it to interact effectively with substrates and other molecules.

LIAS may also participate in quaternary structures through interactions with other proteins, which can influence its functional capabilities. Post-translational modifications, such as phosphorylation, play a role in regulating the activity of LIAS, potentially affecting its enzymatic efficiency and interactions. The presence of specific domains and folds within the protein structure is essential for its function as an enzyme, facilitating the biosynthesis of lipoic acid. Additionally, splice variant isoforms of LIAS may exist, which could lead to variations in its structure and function, impacting its role in mitochondrial processes. These structural features collectively ensure the proper functioning of LIAS in cellular metabolism.

## Function
The LIAS gene encodes lipoic acid synthase, an enzyme essential for the synthesis of lipoic acid, a cofactor crucial for mitochondrial metabolism. In healthy human cells, LIAS is responsible for inserting sulfur atoms into octanoyl groups to form lipoyl groups, which are necessary for the activity of key enzymes such as pyruvate dehydrogenase and α-ketoglutarate dehydrogenase. These enzymes are critical components of the citric acid cycle, a central pathway in energy production (Cronan2020Progress).

LIAS operates within the mitochondria, where it facilitates the conversion of octanoyl groups to lipoyl groups on the glycine cleavage H protein (GCSH). These lipoyl groups are subsequently transferred to the E2 subunits of dehydrogenases, supporting the function of enzyme complexes involved in energy and carbon metabolism (Cronan2020Progress). The proper function of the LIAS gene ensures the normal operation of these metabolic pathways, preventing severe respiratory deficiencies, muscle weakness, and neurological impairments (Cronan2020Progress).

Mutations in the LIAS gene can lead to metabolic disorders, such as glycine encephalopathy, due to impaired lipoic acid synthesis and mitochondrial dysfunction (Tsurusaki2015Novel).

## Clinical Significance
Mutations in the LIAS gene, which encodes lipoic acid synthetase, are associated with several severe metabolic and neurological disorders. These mutations can lead to mitochondrial diseases characterized by deficiencies in key enzymes such as pyruvate dehydrogenase and α-ketoglutarate dehydrogenase, crucial for the citric acid cycle and energy production. This results in symptoms like severe respiratory deficiencies, muscle weakness, and neurological disorders due to elevated brain glycine levels (Cronan2020Progress). 

Glycine encephalopathy, a rare autosomal recessive disorder, has been linked to novel compound heterozygous mutations in the LIAS gene, such as c.738-2A>G and c.929T>C (p.Met310Thr). These mutations disrupt normal enzyme function, contributing to elevated glycine levels in body fluids and symptoms like acute encephalopathy and developmental delays (Tsurusaki2015Novel).

Altered expression of the LIAS gene is also implicated in diabetic nephropathy, with significantly lower expression levels observed in patients with type 2 diabetes and diabetic nephropathy compared to healthy controls. This reduced expression is associated with disease progression and could serve as a biomarker for early detection (Esawy2020The).

## Interactions
LIAS (lipoic acid synthetase) is known to interact with several proteins, playing a crucial role in cellular processes. One significant interaction is with FDX1, a human ferredoxin, which directly binds to LIAS. This interaction is essential for regulating cellular protein lipoylation, a mitochondrial lipid-based post-translational modification critical for the function of key mitochondrial enzymes involved in the TCA cycle. The binding of FDX1 to LIAS promotes protein lipoylation and is vital for maintaining cell viability, especially under low glucose conditions (Dreishpoon2023FDX1).

The interaction between FDX1 and LIAS has been confirmed through various experimental methods, including a Nano-Luc complementation assay and Microscale Thermophoresis (MST), which measured their binding affinity. These studies demonstrated that FDX1 regulates cellular protein lipoylation through direct binding to LIAS, with a dissociation constant (Kd) of 6 µM, indicating a strong interaction (Dreishpoon2023FDX1).

LIAS is also involved in mitochondrial energy metabolism and antioxidant response, interacting with proteins in oxidative decarboxylation processes, such as pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes, which are crucial for cellular respiration and energy production (Cai2022Comprehensive).


## References


1. (Dreishpoon2023FDX1) FDX1 regulates cellular protein lipoylation through direct binding to LIAS. This article has 5 citations.

[2. (Esawy2020The) Marwa M. Esawy and Mahmoud M. Magdy. The peripheral blood expression of lipoic acid synthetase gene as an early marker for diabetic nephropathy. The Egyptian Journal of Hospital Medicine, 81(1):1320–1325, October 2020. URL: http://dx.doi.org/10.21608/ejhm.2020.113064, doi:10.21608/ejhm.2020.113064. This article has 0 citations.](https://doi.org/10.21608/ejhm.2020.113064)

[3. (Cai2022Comprehensive) Yuan Cai, Qingchun He, Wei Liu, Qiuju Liang, Bi Peng, Jianbo Li, Wenqin Zhang, Fanhua Kang, Qianhui Hong, Yuanliang Yan, Jinwu Peng, Zhijie Xu, and Ning Bai. Comprehensive analysis of the potential cuproptosis-related biomarker lias that regulates prognosis and immunotherapy of pan-cancers. Frontiers in Oncology, August 2022. URL: http://dx.doi.org/10.3389/fonc.2022.952129, doi:10.3389/fonc.2022.952129. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.952129)

[4. (Cronan2020Progress) John E. Cronan. Progress in the enzymology of the mitochondrial diseases of lipoic acid requiring enzymes. Frontiers in Genetics, May 2020. URL: http://dx.doi.org/10.3389/fgene.2020.00510, doi:10.3389/fgene.2020.00510. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2020.00510)

[5. (Tsurusaki2015Novel) Yoshinori Tsurusaki, Ryuta Tanaka, Shino Shimada, Keiko Shimojima, Masaaki Shiina, Mitsuko Nakashima, Hirotomo Saitsu, Noriko Miyake, Kazuhiro Ogata, Toshiyuki Yamamoto, and Naomichi Matsumoto. Novel compound heterozygous lias mutations cause glycine encephalopathy. Journal of Human Genetics, 60(10):631–635, June 2015. URL: http://dx.doi.org/10.1038/jhg.2015.72, doi:10.1038/jhg.2015.72. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/jhg.2015.72)